Use of cytokines and mitogens to inhibit pathological immune responses
US6358506B1 · kind B1 · utility
7Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 4, 2000 |
| Grant date | Mar 19, 2002 |
| Priority date | — |
| Expiry date | May 4, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/599
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is generally related to methods of treating autoimmune diseases, including both antibody-mediated and cell-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.